Qualcomm and Huawei announced a multiyear patent license agreement on October 5, 2026, covering 5G, AI and other technologies. Under the deal, the two companies will license patents to each other, and Qualcomm will buy some of Huawei's US patents. Completion of the transaction requires the necessary regulatory approvals. The joint announcement describes an agreement that pairs licensing of communications standards with the acquisition of computing and AI patents.
This is not simply a case of Huawei using Qualcomm's technology. Qualcomm has also licensed Huawei patents under earlier agreements, so reading the deal as a one-sided reversal of roles overlooks the history. The difference between the right to use a patent and the right to own one is a useful way to understand what each company is after.
Two transactions: a cross-license and a patent purchase
The cross-license the companies announced covers 5G as well as patent portfolios in computing, AI, networking and other areas. The patents Qualcomm will buy, meanwhile, are some of Huawei's US patents related to computing, AI, networking and similar fields. Because the cross-license includes 5G, it would be a mistake to assume that every patent being purchased is a 5G patent. Huawei's announcement describes the two as separate items.
| Element of the deal | Announced scope | What the transaction means |
|---|---|---|
| Cross-license | Both companies' patent portfolios, including 5G, computing, AI and networking | Each side gets permission to use the other's patents |
| Qualcomm's purchase | Some Huawei US patents related to computing, AI, networking and more | Qualcomm acquires rights to the covered patents |
A license is a contract that grants permission to use someone else's patents. A purchase transfers the underlying rights themselves. So Qualcomm's purchase should not be equated with ongoing license payments to Huawei. Cash can change hands under a cross-license as well, but the companies have not disclosed the amount, the royalty rates, or which side pays any balance.
The list and number of patents being bought are also unclear. The fields of AI and computing alone do not reveal which technologies Qualcomm plans to use in which products, and it cannot be read as meaning Qualcomm will adopt specific Huawei semiconductor manufacturing technology. The announcement describes the agreement as multiyear but does not give the exact term.
The executives' comments in the joint announcement reflect this two-way relationship. Qualcomm's head of licensing, John Han, said the deal recognizes the value of Qualcomm's 5G standard-essential patent licensing business. He also acknowledged the value of Huawei's intellectual property, so the recognition of Qualcomm's patents and of Huawei's patents is happening in parallel.
Licensing since 2001 and Huawei's growing patent portfolio
According to Huawei, its patent licensing relationship with Qualcomm began in 2001. Huawei's July 30, 2020 statement also states that under the agreement then in place, Qualcomm was licensed to use some Huawei patents. Huawei granting Qualcomm rights to use its patents is not new to this deal.
The change since then shows up in Huawei's own patent income. The company says that in 2021, its intellectual property licensing revenue exceeded its outbound royalty payments for the first time. That figure reflects the company's overall finances and does not indicate the direction of payments under the Qualcomm contract specifically. Still, it shows how a company that used others' technology has grown into one that earns income from others using its own. Huawei's intellectual property materials show both roles coexisting.
Huawei says its R&D spending in 2025 was RMB 192.3 billion, equal to 21.8% of revenue, and that it held more than 165,000 active patents worldwide at the end of that year. These figures cover patents in all fields, not just 5G essential patents, and they differ from the number being sold here. But they indicate the scale of a business that aims to turn years of research into revenue through both products and patents.
That said, the value of this deal cannot be calculated from published rates. Huawei's handset licensing program caps the 5G royalty at US$2.5 per device, but a footnote says it is a one-way rate conditioned on reciprocity. That is a term for end devices and cannot simply be applied to a broad cross-license with a chipmaker or to the price of a patent sale.
Patent income exceeding payments is also a different matter from receiving a net balance from a counterparty in a given deal. Growth in Huawei's patent business is verifiable, but it does not by itself determine the financial outcome of this agreement.
The licensing business behind Qualcomm's profits
Qualcomm runs QCT, which sells chips, and QTL, which licenses patents, as separate businesses. The difference is clear in its fiscal third-quarter 2026 results. For the quarter ended June 28, the two segments compare as follows.
| Metric | QCT (semiconductors) | QTL (licensing) |
|---|---|---|
| Revenue | $8,504 million | $1,278 million |
| Pre-tax earnings | $2,192 million | $881 million |
| Pre-tax margin | 26% | 69% |
In Qualcomm's fiscal third quarter of 2026, QTL's pre-tax margin was 69%, 43 percentage points above QCT's 26%. The gap is calculated as 69 minus 26 from the reported whole-number margins, so it includes rounding. QCT has the larger revenue, but QTL generates much more pre-tax profit relative to its sales. The comparison is of each segment's pre-tax margin, not the company's net margin or the margin on the Huawei deal.
Understanding QTL's earnings requires understanding standard-essential patents (SEPs). Patented technologies built into a communications standard, which cannot be avoided when implementing it, are relevant even when a company designs its own chips. Where a company buys product components and who it gets a license from for patents needed to implement the standard are separate questions.
The standards body ETSI recognizes that patent holders should be rewarded for their research while allowing implementers to use the technology, and its principle is licensing on FRAND (fair, reasonable and non-discriminatory) terms. However, according to ETSI's explanation, specific terms and negotiations are commercial matters between companies, not something ETSI decides. The fact that the two companies invoked FRAND does not reveal royalty rates or cash flows.
Given this business structure, Qualcomm has reason to turn patent use into revenue even when the buyers of its chips change. The cross-license with Huawei continues that business, and the purchase of US patents can be read as a transaction that expands the assets Qualcomm holds. But the companies have not disclosed the financial impact of the deal, so a high margin alone is no basis for forecasting higher profits.
The patent deal does not signal a return of chip supply
In a May 9, 2024 filing with the US Securities and Exchange Commission, Qualcomm disclosed that on May 7 the US Department of Commerce had revoked, effective immediately, its licenses to export certain integrated circuit products, including 4G and Wi-Fi products, to Huawei. Separately from patent licensing contracts, permission to ship products has been a longstanding issue.
What was announced this time is patent licensing and the acquisition of some US patents. The companies did not announce a resumption of Qualcomm chip supply or the granting of export licenses for Huawei. The joint announcement also makes the deal conditional on the necessary regulatory approvals, but it does not name the approving authorities or an expected closing date. Treating the patent agreement, the completion of the rights transfer and product exports as a single event would read too much into the announcement.
Still, it matters that product sales and patent monetization can move on separate tracks. Huawei offers technology that others want to use as an asset, while Qualcomm grants use of its communications patents and acquires rights in other fields. Even as the two companies keep competing, transactions through patents can go forward.
Once regulatory approvals are secured and the acquired patents, along with the products that use the technology, become clear, it will be possible to assess what the deal adds to Qualcomm's AI and computing business. How far Huawei's research results spread into other companies' products will also become visible through their concrete use.